![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, October 14, 2014 8:34:59 PM
In order for that to happen, the specific protocols would have been identified, the approval would have come before that, and so many things would have to have happened, none of which have happened yet.
In other news, the principal investigator along with LOTS of other standard milestones have NOT been announced and it is mid October, an Eltoprazine study this year or even in the first quarter is difficult to predict.
Once again, GC is over promising because he needs the currency. His actions could NOT reflect a more incompetent CEO.
Nothing hurts more than dashed hopes. In this case, hopes have been dashed so many times, I've lost track.
The truth is incontrovertible. Malice may attack it, ignorance may deride it, but in the end, there it is.
Winston Churchill
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM